Skip to main content
Top
Published in: Annals of Surgical Oncology 10/2012

01-10-2012 | Breast Oncology

Fear of Recurrence and Perceived Survival Benefit are Primary Motivators for Choosing Mastectomy over Breast-Conservation Therapy Regardless of Age

Authors: Carla S. Fisher, MD, Tonya Martin-Dunlap, MD, Megan Baker Ruppel, MD, Feng Gao, PhD, Jordan Atkins, BS, Julie A. Margenthaler, MD, FACS

Published in: Annals of Surgical Oncology | Issue 10/2012

Login to get access

Abstract

Introduction

Recent studies have reported increases in the rate of mastectomy and contralateral prophylactic mastectomy (CPM). We hypothesized that there would be different reasons for choosing mastectomy for women aged <50 compared with those aged ≥50 years.

Methods

A questionnaire was administered to 332 patients who underwent unilateral or bilateral mastectomy for breast cancer from 2006 to 2010. The survey queried on demographics, surgical choices, and rationale for those choices. A retrospective chart review was performed to determine tumor characteristics. Responses and clinical characteristics were described by contingency tables and compared using Fisher exact test or χ2 test, as appropriate.

Results

Of 332 patients surveyed, 310 were evaluable. Median age was 55 years, including 88 patients <50 (28 %) and 222 patients ≥50 (72 %) at time of diagnosis. Forty-four percent of women <50 and 41 % of women ≥50 were given the option of breast conservation and chose mastectomy (p > 0.63). The two groups did not differ in their reason for choosing mastectomy, with lower recurrence risk and improved survival cited as the two most common reasons. Younger patients were more likely to undergo reconstruction and CPM (p < 0.0001) as well as have estrogen receptor-negative tumors, undergo neoadjuvant chemotherapy, and have higher magnetic resonance imaging utilization (p < 0.05).

Conclusions

Choosing mastectomy and the reasons for doing so were the same for women aged <50 and ≥50 years. Prospective studies are needed to determine whether patient education regarding perceived versus actual recurrence risk and survival would alter this decision-making process.
Literature
1.
go back to reference NIH Consensus conference. Treatment of early-stage breast cancer. JAMA. 1991;265:391–5.CrossRef NIH Consensus conference. Treatment of early-stage breast cancer. JAMA. 1991;265:391–5.CrossRef
2.
go back to reference Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 1985;312:665–73.PubMedCrossRef Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 1985;312:665–73.PubMedCrossRef
3.
go back to reference Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233–41.PubMedCrossRef Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233–41.PubMedCrossRef
4.
go back to reference Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227–32.PubMedCrossRef Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227–32.PubMedCrossRef
5.
go back to reference Jacobson JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 1995;332(14):907–11.PubMedCrossRef Jacobson JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 1995;332(14):907–11.PubMedCrossRef
6.
go back to reference Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy. Cancer. 2003;98(4):697–702.PubMedCrossRef Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy. Cancer. 2003;98(4):697–702.PubMedCrossRef
7.
go back to reference Arriagada RM, Lê MG, Guinebretière J.-M., et al. Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol. 2003;14(11):1617–22.PubMedCrossRef Arriagada RM, Lê MG, Guinebretière J.-M., et al. Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol. 2003;14(11):1617–22.PubMedCrossRef
8.
go back to reference Tuttle TM, Habermann EB, Grund EH, et al. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25(33):5203–09.PubMedCrossRef Tuttle TM, Habermann EB, Grund EH, et al. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25(33):5203–09.PubMedCrossRef
9.
go back to reference McGuire K, Santillan A, Kaur P, et al. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol. 2009;16(10):2682–90.PubMedCrossRef McGuire K, Santillan A, Kaur P, et al. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol. 2009;16(10):2682–90.PubMedCrossRef
10.
go back to reference Arrington A, Jarosek S, Virnig B, et al. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol. 2009;16(10):2697–704.PubMedCrossRef Arrington A, Jarosek S, Virnig B, et al. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol. 2009;16(10):2697–704.PubMedCrossRef
11.
go back to reference King TA, Sakr R, Patil S, et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol. 2011;29(16):2158–64.PubMedCrossRef King TA, Sakr R, Patil S, et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol. 2011;29(16):2158–64.PubMedCrossRef
12.
go back to reference Tuttle TM, Jarosek S, Habermann EB, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27(9):1362–67.PubMedCrossRef Tuttle TM, Jarosek S, Habermann EB, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27(9):1362–67.PubMedCrossRef
13.
go back to reference Fancher TT, Palesty JA, Thomas R, et al. A woman’s influence to choose mastectomy as treatment for breast cancer. J Surg Res. 2009;153(1):128–31.PubMedCrossRef Fancher TT, Palesty JA, Thomas R, et al. A woman’s influence to choose mastectomy as treatment for breast cancer. J Surg Res. 2009;153(1):128–31.PubMedCrossRef
14.
go back to reference Hiotis K, Ye W, Sposto R, et al. Predictors of breast conservation therapy. Cancer. 2005;103(5):892–99.PubMedCrossRef Hiotis K, Ye W, Sposto R, et al. Predictors of breast conservation therapy. Cancer. 2005;103(5):892–99.PubMedCrossRef
15.
go back to reference Chagpar AB, Studts JL, Scoggins CR, et al. Factors associated with surgical options for breast carcinoma. Cancer. 2006;106(7):1462–66.PubMedCrossRef Chagpar AB, Studts JL, Scoggins CR, et al. Factors associated with surgical options for breast carcinoma. Cancer. 2006;106(7):1462–66.PubMedCrossRef
16.
go back to reference Chan A, Pintilie M, Vallis K, et al. Breast cancer in women < or = 35 years: review of 1002 cases from a single institution. Ann Oncol. 2000;11(10):1255–62.PubMedCrossRef Chan A, Pintilie M, Vallis K, et al. Breast cancer in women < or = 35 years: review of 1002 cases from a single institution. Ann Oncol. 2000;11(10):1255–62.PubMedCrossRef
17.
go back to reference Neff P, Bear H, Pierce C, et al. Long-term results of breast conservation therapy for breast cancer. Ann Surg. 1996;223:709–17.PubMedCrossRef Neff P, Bear H, Pierce C, et al. Long-term results of breast conservation therapy for breast cancer. Ann Surg. 1996;223:709–17.PubMedCrossRef
18.
go back to reference Buckley J, Coopey S, Samphao S, et al. Recurrence rates and long-term survival in women diagnosed with breast cancer at age 40 and younger. Presented at 2011 breast cancer symposium; 2011. Buckley J, Coopey S, Samphao S, et al. Recurrence rates and long-term survival in women diagnosed with breast cancer at age 40 and younger. Presented at 2011 breast cancer symposium; 2011.
19.
go back to reference Khan SA. Contralateral prophylactic mastectomy: what do we know and what do our patients know? J Clin Oncol. 2011;29(16):2132–35.PubMedCrossRef Khan SA. Contralateral prophylactic mastectomy: what do we know and what do our patients know? J Clin Oncol. 2011;29(16):2132–35.PubMedCrossRef
Metadata
Title
Fear of Recurrence and Perceived Survival Benefit are Primary Motivators for Choosing Mastectomy over Breast-Conservation Therapy Regardless of Age
Authors
Carla S. Fisher, MD
Tonya Martin-Dunlap, MD
Megan Baker Ruppel, MD
Feng Gao, PhD
Jordan Atkins, BS
Julie A. Margenthaler, MD, FACS
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 10/2012
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-012-2525-x

Other articles of this Issue 10/2012

Annals of Surgical Oncology 10/2012 Go to the issue